Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids

被引:22
|
作者
Mallory, S
Sommer, M
Arvin, AM [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Immunol Microbiol, Stanford, CA 94305 USA
来源
关键词
D O I
10.1086/514277
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The contributions of the glycoproteins gI (ORF67) and gE (ORF68) to varicella-zoster virus (VZV) replication were investigated in deletion mutants made by using cosmids with VZV DNA derived from the Oka strain. These experiments demonstrated that gI was not required for VZV replication in vitro but gE appeared to be. Although VZV gI was not required, its deletion or mutation resulted in a significant decrease in infectious virus yields, and it disrupted syncytial formation and altered the conformation and distribution of gE in infected cells. Normal cell-to-cell spread and replication kinetics were restored when gI was expressed from a non-native locus in the VZV genome. The expression of intact gI, the ORF67 gene product, is required for efficient VZV replication.
引用
收藏
页码:S22 / S26
页数:5
相关论文
共 50 条
  • [1] SYNTHESIS AND PROCESSING OF GLYCOPROTEINS OF VARICELLA-ZOSTER VIRUS (VZV) AS STUDIED WITH MONOCLONAL-ANTIBODIES TO VZV ANTIGENS
    OKUNO, T
    YAMANISHI, K
    SHIRAKI, K
    TAKAHASHI, M
    [J]. VIROLOGY, 1983, 129 (02) : 357 - 368
  • [2] Vaccines against varicella-zoster virus (VZV)
    Salleras, Luis
    Salleras, Montserrat
    Soldevila, Nuria
    Prat, Andreu
    Garrido, Patricio
    Dominguez, Angela
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2015, 33 (06): : 411 - 423
  • [3] Immunogenicity of the whole antigen and glycoprotein I of Varicella-zoster virus (VZV) and the VZV skin test antigen
    Kawano, S
    Terada, K
    Hiraga, Y
    Morita, T
    [J]. ACTA PAEDIATRICA JAPONICA, 1996, 38 (02): : 121 - 123
  • [4] Issues in varicella-zoster virus (VZV) ganglionic latency
    Kennedy, Peter G.
    [J]. JOURNAL OF NEUROVIROLOGY, 2006, 12 : 38 - 39
  • [5] Seroprevalence of varicella-zoster virus (VZV) in the French population
    Debruyne, M
    Floret, D
    Khoshnood, B
    Emery, C
    Fagnani, F
    Lancon, F
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S240 - S240
  • [6] Varicella-zoster virus (VZV) DNA in serum of patients with VZV central nervous system infections
    Grahn, Anna
    Bergstrom, Tomas
    Runesson, Jim
    Studahl, Marie
    [J]. JOURNAL OF INFECTION, 2016, 73 (03) : 254 - 260
  • [7] Multifocal vasculopathy due to varicella-zoster virus (VZV): Serial analysis of VZV DNA and intrathecal synthesis of VZV antibody in cerebrospinal fluid
    Kronenberg, A
    Schupbach, R
    Schuknecht, B
    Bossart, W
    Weber, R
    Gilden, DH
    Speck, RF
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 35 (03) : 330 - 333
  • [8] POLYPEPTIDES OF VARICELLA-ZOSTER VIRUS (VZV) AND IMMUNOLOGICAL RELATIONSHIP OF VZV AND HERPES-SIMPLEX VIRUS (HSV)
    SHIRAKI, K
    OKUNO, T
    YAMANISHI, K
    TAKAHASHI, M
    [J]. JOURNAL OF GENERAL VIROLOGY, 1982, 61 (AUG): : 255 - 269
  • [9] The molecular epidemiology of varicella-zoster virus (VZV) in Czech Republic
    Bostik, V.
    Chlibek, R.
    Salavec, M.
    Smetana, J.
    Kosina, P.
    Prasil, P.
    Plisek, S.
    Splino, M.
    Bostick, P.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E123 - E123
  • [10] Molecular biological and epidemiological characteristics of the varicella-zoster virus (VZV)
    Vanda, Bostikova
    Roman, Chlibek
    Miloslav, Salavec
    Jan, Smetana
    Radek, Sleha
    Miroslav, Splino
    Pavel, Bostik
    [J]. EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2013, 62 (04): : 148 - 152